231 filings
15-12G
SIOX
Sio Gene Therapies Inc.
25 Apr 23
Securities registration termination
4:04pm
EFFECT
SIOX
Sio Gene Therapies Inc.
25 Apr 23
Notice of effectiveness
12:15am
POS AM
SIOX
Sio Gene Therapies Inc.
17 Apr 23
Prospectus update (post-effective amendment)
4:15pm
S-8 POS
SIOX
Sio Gene Therapies Inc.
17 Apr 23
Registration of securities for employees (post-effective amendment)
4:12pm
25-NSE
SIOX
Sio Gene Therapies Inc.
12 Apr 23
Exchange delisting
8:52am
25
jyo5974t c5
6 Apr 23
Voluntary exchange delisting
4:07pm
8-K
v4avzmhc8dwm f0j
6 Apr 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
cn0 iyen3qfuw1j8ry
16 Mar 23
Additional proxy soliciting materials
9:36pm
8-K
l2ezf8 uqz7bduva
15 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:25pm
DEFM14A
abrot7pk
21 Feb 23
Proxy related to merger
4:05pm
DEFA14A
xymqom8v2
14 Feb 23
Additional proxy soliciting materials
7:03am
8-K
vdy7jmb
14 Feb 23
Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
7:01am
PREM14A
f9z8 f7372
8 Feb 23
Preliminary proxy related to merger
5:56pm
DEFA14A
36sh7s qj9nim8
14 Dec 22
Additional proxy soliciting materials
4:10pm
8-K
3d5nlv
14 Dec 22
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
4:04pm
8-K
4y9p5zy3
10 Nov 22
Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial Results
7:03am
8-K
lrk7ef
14 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:08pm
8-K
dnx3rtbrxa33njqjp2
11 Aug 22
Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results
7:05am